Świerczek, A.; Pociecha, K.; Plutecka, H.; Ślusarczyk, M.; Chłoń-Rzepa, G.; Wyska, E.
Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases. Pharmaceutics 2022, 14, 1090.
https://doi.org/10.3390/pharmaceutics14051090
AMA Style
Świerczek A, Pociecha K, Plutecka H, Ślusarczyk M, Chłoń-Rzepa G, Wyska E.
Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases. Pharmaceutics. 2022; 14(5):1090.
https://doi.org/10.3390/pharmaceutics14051090
Chicago/Turabian Style
Świerczek, Artur, Krzysztof Pociecha, Hanna Plutecka, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa, and Elżbieta Wyska.
2022. "Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases" Pharmaceutics 14, no. 5: 1090.
https://doi.org/10.3390/pharmaceutics14051090
APA Style
Świerczek, A., Pociecha, K., Plutecka, H., Ślusarczyk, M., Chłoń-Rzepa, G., & Wyska, E.
(2022). Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases. Pharmaceutics, 14(5), 1090.
https://doi.org/10.3390/pharmaceutics14051090